After CEO move, GSK picks ex-Novartis exec to head consumer unit
- Record-setting rally pushes on as S&P ends week up 3 percent
- Trump's Cohn Pick Most Bullish Sign Yet for Banks - Cowen
- Unusual 11 Mid-Day Movers: (IDXG) (INVN) (EBS) Higher; (SCON) (DTEA) (DLTH) Lower (more...)
- 21st Century Fox (FOXA) offers to acquire Sky for GBP10.75/share
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008. REUTERS/Toby Melville/File Photo
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
LONDON (Reuters) - GlaxoSmithKline (NYSE: GSK) has promoted a former Novartis (NASDAQ: NOVN) executive to lead its consumer healthcare business, following the appointment last week of the unit's previous head, Emma Walmsley, as CEO designate of the drugmaker.
The British group said on Thursday that Brian McNamara, 50, who currently heads up Europe and the Americas at GSK Consumer Healthcare, would take on his new role immediately and join GSK's corporate executive team.
McNamara worked for 11 years at Novartis, where he was also in charge of consumer health, and joined GSK following the creation of a joint venture between the two companies in 2015. Prior to that he spent 16 years at Procter & Gamble (NYSE: PG).
The swift management transition will ensure the consumer business remains focused on improving financial performance and will allow Walmsley to focus on her new role as incoming CEO, a spokesman said.
She will officially take the helm at the end of March on the retirement of current CEO Andrew Witty, becoming the first woman to lead a top global drugmaker.
Separately, GSK said it had disposed of the final portion of its stake in Aspen Pharmacare
(Reporting by Ben Hirschler; Editing by Adrian Croft)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Taliban chief reinforces position with backing of two key members
- Colombian president receives Nobel Prize for peace accord
- Egyptian court rejects appeal by Islamist militant Adel Habara over death sentence
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!